Evidence map›Paper›PMID 33996636›Full record

ArticleFrontiers in cellular and infection microbiology2021

Characterization and Follow-Up of

Arturo Muñoz-Calderón, Zoraida Díaz-Bello, Belkisyolé Alarcón de Noya, Oscar O Noya-González, Alejandro G Schijman

Open access · goldAbstract read
In one paragraph

Article in Frontiers in cellular and infection microbiology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed, 1 pooled it
0.8field-weighted citation impact, top 29% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 1 synthesis or guideline pooled it, 8 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Clinical Progression of Cardiac ChronicPathogens (Basel, Switzerland) · 2025
    Article
  4. Review
  5. Article
  6. Review
  7. Clinical use of molecular methods forFrontiers in parasitology · 2023
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 2 countries.

Arturo Muñoz-CalderónLaboratorio de Biología Molecular de la Enfermedad de Chagas, Instituto de Investigaciones en Ingeniería Genética y Biología Molecular (INGEBI), Consejo Nacional de Investigaciones Científicas y Técnicas (CONICET), Buenos Aires, Argentina.
Zoraida Díaz-BelloInstituto de Medicina Tropical "Dr Félix Pifano", Universidad Central de Venezuela, Caracas, Venezuela.
Belkisyolé Alarcón de NoyaInstituto de Medicina Tropical "Dr Félix Pifano", Universidad Central de Venezuela, Caracas, Venezuela.
Oscar O Noya-GonzálezInstituto de Medicina Tropical "Dr Félix Pifano", Universidad Central de Venezuela, Caracas, Venezuela.
Alejandro G SchijmanLaboratorio de Biología Molecular de la Enfermedad de Chagas, Instituto de Investigaciones en Ingeniería Genética y Biología Molecular (INGEBI), Consejo Nacional de Investigaciones Científicas y Técnicas (CONICET), Buenos Aires, Argentina.
Central University of Venezuela · VEConsejo Nacional de Investigaciones Científicas y Técnicas · ARExperimental Medicine and Biology Institute · AR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

We aimed to characterize the genetic constitution of natural

Indexed as

Chagas DiseaseTrypanosoma cruziDNA, ProtozoanFollow-Up StudiesHumansParasite LoadReal-Time Polymerase Chain ReactionDNA, Protozoangenetic diversityminicircle signatureOral Chagas diseaseparasite loadrestriction fragment length polymorphismtherapeutic failuretrypanocidal chemotherapyTrypanosoma cruzi

Identifiers

PMID33996636
PMCPMC8121101
OpenAlexW3159887712

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.